Portfolio Update

MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc All information is at 31 December 2007 and unaudited. Performance at month end with net income reinvested One Three One Since Launch Month Months Year (20Sep04) Net asset value 2.7% 2.3% 14.6% 102.5% Share price 3.6% 1.5% 14.3% 93.5% FTSE World Europe ex UK 1.9% 3.0% 15.7% 91.1% Sources: BlackRock and Datastream At month end Net asset value (capital only): 195.26p Net asset value (including income): 195.17p* Share price: 186.25p *Includes net revenue of (0.09p) Discount to NAV (capital only): 4.6% Discount to NAV (including income): 4.6% Gearing: 2.3% Net yield: 1.3% Total assets: £230.0m Ordinary shares in issue: 115,117,791 Sector Analysis Total Assets Index Country Analysis Total Assets (%) (%) (%) Financials 25.1 28.6 Germany 23.9 Basic Materials 12.2 6.8 France 13.8 Health Care 11.5 6.5 Switzerland 10.3 Utilities 10.2 8.5 Italy 8.8 Consumer Goods 9.0 14.1 Netherlands 7.5 Oil & Gas 7.7 6.4 Spain 5.4 Telecommunications 6.4 6.9 Finland 4.7 Technology 5.8 4.2 Russia 4.3 Industrials 5.4 12.9 Emerging Europe 3.6 Consumer Services 3.7 5.1 Belgium 2.4 Other Investments 3.7 Israel 2.2 Net current liabilities (0.7) USA 2.1 Greece 2.1 Turkey 1.8 Austria 1.5 Norway 1.5 Ireland 1.5 UK 1.2 Poland 1.1 Luxembourg 1.0 Net current liabilities (0.7) ----- ----- ----- 100.0 100.0 100.0 ===== ===== ===== Ten Largest Equity Investments Company Country of Risk Banco Santander Spain Bayer Germany BlackRock Eurasian Frontiers Hedge Fund Emerging Europe Electricite de France France ENI Italy E.On Germany Intesa Sanpaolo Italy Nokia Finland Novartis Switzerland Siemens Germany Commenting on the markets, James Macmillan, representing the Investment Manager noted: European equity markets advanced modestly in December, despite increasing concern about the impact of the US sub-prime and credit crisis on economic growth in Europe. Emerging Europe continued to underperform the developed European markets reversing the trend seen for most of the year. The FTSE World Europe ex UK Index (NDR) returned 1.9% through December and the MSCI Emerging Europe returned 1.7% in Sterling terms. The Company's NAV returned 2.7% outperforming the reference index. The contribution from the Emerging Europe region was positive, with the Company benefiting from its exposure to Russia and Turkey. The Company's performance was positively impacted by positive gearing in a rising market. During the month the Company benefited from its exposure to materials and stock selection within this sector contributed positively; notably positions in steel giant Arcelor Mittal, and chemical companies Akzo Nobel and Bayer were the most positive. In addition, a position in Turkish printing company, Koza Davetiyeleri along with selected stocks in the telecoms (Hellenic Telecoms) and banks (Allied Irish and Santander) sectors also had a positive contribution to performance. The Company's exposure to the consumer durables sector through Turkish Vestel Elektronik Sanayi Ve Ticaret, the insurance sector (AXA), utilities sector (Iberdrola) and pharmaceutical sector (Roche and Novartis) all detracted from performance through December. During the month, the Company reduced its holdings in the energy sector through the sale of Gazprom and Statoilhydro, and the technology sector through the trimming of the position in Nokia. The proceeds were used to increase holdings in software and services company Cap Gemini, which we saw as undervalued and the Materials and Diversified Financials sectors. The Company continues to have a bias towards financials through banks, along with pharmaceuticals, materials and utilities. Exposure to Emerging Europe increased during the month to finish at 13.0%, with the largest country exposures being Turkey and Russia, along with the BlackRock Eurasian Frontiers Hedge Fund which provides diversified exposure to the region. During the month, the Company significantly reduced its net market exposure to 102.3%. We remain positive on the medium term prospects for European and Emerging European equities, although the risk of near term volatility is high. The key risk is that of global recession but if current consensus expectations of continued growth in Emerging Markets prove robust, then European companies can continue to deliver profit growth on the back of sales expansion and productivity benefits. The overall valuation of the European equity market looks reasonable and there are some stocks in cyclical sectors which look very cheap, after the recent market weakness. M&A is likely to continue to be supportive as many sectors consolidate across borders within Europe. We are likely to be opportunistic buyers into any market weakness. Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). 22 January 2008
UK 100

Latest directors dealings